Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Mutations in the WNT10A gene cause Short Anagen Hair syndrome and increase the risk of male pattern hair loss.

TGFβ-2 may cause hair loss in androgenetic alopecia.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Activated ras can protect kidney cells from a certain substance that causes cell death.

HOXC13 is essential for hair and nail development by regulating Foxn1.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

LncRNA RP11-818024.3 helps hair growth and recovery in hair loss by boosting cell survival and reducing cell death.

Overactive Stat3 in mouse skin causes hair loss and cell structure damage.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The document's conclusion cannot be provided because the content is not available.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

TACE/ADAM17 is essential for maintaining healthy hair and hair follicle stem cells.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Defective nuclear transport may cause gene expression changes in Progeria.